Choose an area:

Targeted and Improved Alzheimer's Disease Drug Development

Department 58 – International Relations
Department 58 – International Relations

Published

Project
Region Hradec Králové Region
Title of the ProgrammeResearch
Title of the ProjectTargeted and Improved Alzheimer's Disease Drug Development
Project Website

https://pahnkelab.eu
https://www.fnhk.cz/opp/projekty/realizovane/tacr-kappa

Number of the ProjectTO01000078
Project Promoter

Fakultní nemocnice Hradec Králové

Project Partner from Donor State

University of Oslo

Czech Partner

Bioinova, s.r.o.
Ústav experimentální medicíny AV ČR, v. v. i.

 

Status

Estimated project duration: 1/2021 - 4/2024

Total Eligible Costs

1 451 470 EUR

Grant

1 378 705 EUR

Project description:

The aim of the project is the development of compounds for the treatment of Alzheimer´s disease (AD).

The project will include an approaches of personalized medicine during the development process in the way that novel compounds will be tested in a disease in a dish (DiD) model derived from AD patients.